Christina Rossi's Insider Trades & SAST Disclosures
Christina Rossi's most recent trade in Blueprint Medicines Corp was a trade of 6,495 Common Stock done at an average price of $88.8 . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christina Rossi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 6,495 | 71,540 (0%) | 0% | 88.8 | 576,756 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 13,200 | 78,035 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.14 per share. | 20 Feb 2025 | 2,274 | 64,835 (0%) | 0% | 95.1 | 216,348 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 21 Jan 2025 | 816 | 68,038 (0%) | 0% | 110 | 89,760 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 110.78 per share. | 21 Jan 2025 | 808 | 67,230 (0%) | 0% | 110.8 | 89,510 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 108.99 per share. | 21 Jan 2025 | 529 | 68,854 (0%) | 0% | 109.0 | 57,656 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 111.81 per share. | 21 Jan 2025 | 121 | 67,109 (0%) | 0% | 111.8 | 13,529 | Common Stock |
| Blueprint Medicines Corp | Rossi Christina | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.88 per share. | 18 Dec 2024 | 2,166 | 69,491 (0%) | 0% | 95.9 | 207,676 | Common Stock |
| Blueprint Medicines Corp | Rossi Christina | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 96.50 per share. | 18 Dec 2024 | 108 | 69,383 (0%) | 0% | 96.5 | 10,422 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.10 per share. | 27 Nov 2024 | 2,274 | 71,657 (0%) | 0% | 95.1 | 216,257 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 9,625 | 73,931 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 6,070 | 64,306 (0%) | 0% | 90.7 | 550,488 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 70,376 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 2,960 | 55,475 (0%) | 0% | 45.7 | 135,331 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 44.28 per share. | 06 Mar 2023 | 99 | 55,376 (0%) | 0% | 44.3 | 4,384 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,000 | 58,435 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 45.24 per share. | 03 Nov 2022 | 533 | 43,435 (0%) | 0% | 45.2 | 24,113 | Common Stock |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.28 per share. | 03 Mar 2022 | 1,197 | 45,526 (0%) | 0% | 60.3 | 72,155 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 03 Mar 2022 | 1,047 | 44,479 (0%) | 0% | 56.2 | 58,831 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 15,000 | 46,723 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 86.61 per share. | 04 Mar 2021 | 1,272 | 31,723 (0%) | 0% | 86.6 | 110,168 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 89.10 per share. | 04 Mar 2021 | 87 | 32,995 (0%) | 0% | 89.1 | 7,752 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 26,125 | 26,125 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 13,062 | 33,082 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 99.69 per share. | 03 Nov 2020 | 345 | 20,020 (0%) | 0% | 99.7 | 34,393 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges